WORLD News & Analysis
Tags: PHARMACEUTICAL industry; CLINICAL trials; DRUGS -- Testing
Related Articles
- Drug trial GPs set to lose �30k. // Pulse;11/3/2003, Vol. 63 Issue 44, p21
Reports that primary care organizations (PCO) are demanding a role in the approval for clinical drug trials in Great Britain. Financial losses in clinical research contracts faced by physicians; Pharmaceutical firms' decision to bring their trials overseas.
- Clinic Roundup. // BioWorld Today;12/27/2010, Vol. 21 Issue 248, p2
This section offers news briefs on clinical trials, including a Phase IIb trial by Myrexia Inc. of its Azixa molecule serving as a microtubule destabilizing agent in front-line glioblastoma multiforme, the successful enrollment to the Phase II study by Spectrum Pharmaceuticals Inc. for its HDAC...
- R&D news. // Pharmaceutical Executive;Jan1999, Vol. 19 Issue 1, p104
Presents news on research and development in the pharmaceutical industry. Details on the Phase II clinical trials involving Medarex's anti-HER-2 cancer product, MDX-210; Information on a study which proved that Miacalcin, a calcitronin-salmon nasal spray, can reduce the risk of spinal fracture...
- Testing Products in China. // Pharmaceutical Executive;May2002, Vol. 22 Issue 5, p20
Reports on the move of U.S. pharmaceutical companies towards testing products in China. Factors that make Chinese research trials relatively easy and affordable; Information on some companies that conducted trials in the country; Characteristics of drug testing in China.
- Opinion Leaders. Sachtleben, Stefan // Deutsches Aerzteblatt International;9/24/2010, Vol. 107 Issue 38, p5
The author comments on an article on the financing of drug trials by pharmaceutical companies, published in previous issues of the journal. He says that the presence of a substantial number of doctors who volunteer to act as authors, representatives, or opinion leaders generally, can lead to...
- Reverse Auctions: Crusade or Curse? Gehrke, Allen R.; Faulkner, Elizabeth; van Dijk, Cindy // Applied Clinical Trials;Jan2007, Vol. 16 Issue 1, p38
The article focuses on the increase in the adoption of reverse auction (RA) as a strategy in the procurement of drug development goods and services in the U.S. The major benefit of RAs to drug companies is the establishment of a competitive environment and lower prices. However, RAs may create...
- Pharma tests under fire. O'Driscoll, Cath // European Chemical News;9/19/2005, Vol. 83 Issue 2163, p44
This article focuses on the controversies concerning the participation of volunteers in the long-term clinical trials of unapproved drugs. The criticism is directed at open label extension studies (OLES) carried out by pharmaceutical companies ostensibly to evaluate the long term safety and...
- TeGenero: bankruptcy beckons. // PharmaWatch: Cancer;Aug2006, Vol. 5 Issue 8, p5
The article reports that German biotech firm TeGenero AG has filed for bankruptcy after a catastrophic safety trial with its immunodulatory drug candidate TGN1412. The drug was developed for the treatment of certain autoimmune diseases and leukemia. The company states that the principal reason...
- Multiple Sclerosis Update. // PharmaWatch: CNS;Apr2005, Vol. 4 Issue 4, p6
The article provides updates related to multiple sclerosis in Europe. Renovis initiated a clinical trial to assess the safety, tolerability and pharmacokinetics of REN-850. Two pharmaceutical companies in the U.S. have suspended sales of their innovative multiple sclerosis treatment Tysabri...
